The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha
- PMID: 12890694
- DOI: 10.1096/fj.02-1038com
The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha
Abstract
In this study we addressed the role of sphingolipid metabolism in the inflammatory response. In a L929 fibroblast model, tumor necrosis factor-alpha (TNF) induced prostaglandin E2 (PGE2) production by 4 h and cyclooxygenase-2 (COX-2) induction as early as 2 h. This TNF-induced PGE2 production was inhibited by NS398, a COX-2 selective inhibitor. GC-MS analysis revealed that only COX-2-generated prostanoids were produced in response to TNF, thus providing further evidence of COX-2 selectivity. As sphingolipids have been implicated in mediating several actions of TNF, their role in COX-2 induction and PGE2 production was evaluated. Sphingosine-1-phosphate (S1P) induced both COX-2 and PGE2 in a dose-responsive manner with an apparent ED50 of 100-300 nM. The related sphingolipid sphingosine also induced PGE2, though with much less efficacy. TNF induced a 3.5-fold increase in sphingosine-1-phosphate levels at 10 min that rapidly returned to baseline by 40 min. Small interfering RNAs (siRNAs) directed against mouse SK1 decreased (typically by 80%) SK1 protein and inhibited TNF-induced SK activity. Treatment of cells with RNAi to SK1 but not SK2 almost completely abolished the ability of TNF to induce COX-2 or generate PGE2. By contrast, cells treated with RNAi to S1P lyase or S1P phosphatase enhanced COX-2 induction leading to enhanced generation of PGE2. Treatment with SK1 RNAi also abolished the effects of exogenous sphingosine and ceramide on PGE2, revealing that the action of sphingosine and ceramide are due to intracellular metabolism into S1P. Collectively, these results provide novel evidence that SK1 and S1P are necessary for TNF to induce COX-2 and PGE2 production. Based on these findings, this study indicates that SK1 and S1P could be implicated in pathological inflammatory disorders and cancer.
Similar articles
-
De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.Cell Signal. 2006 Oct;18(10):1779-92. doi: 10.1016/j.cellsig.2006.01.018. Epub 2006 Mar 10. Cell Signal. 2006. PMID: 16529909
-
Sphingosine kinase 1 is up-regulated in colon carcinogenesis.FASEB J. 2006 Feb;20(2):386-8. doi: 10.1096/fj.05-4331fje. Epub 2005 Nov 30. FASEB J. 2006. PMID: 16319132
-
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.Arthritis Rheum. 2006 Mar;54(3):742-53. doi: 10.1002/art.21668. Arthritis Rheum. 2006. PMID: 16508938
-
Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.Handb Exp Pharmacol. 2013;(216):3-27. doi: 10.1007/978-3-7091-1511-4_1. Handb Exp Pharmacol. 2013. PMID: 23563649 Review.
-
Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.Biochim Biophys Acta. 2002 Dec 30;1585(2-3):193-201. doi: 10.1016/s1388-1981(02)00341-4. Biochim Biophys Acta. 2002. PMID: 12531554 Review.
Cited by
-
Predicting significance of COX-2 expression of peripheral blood monocyte in patients with coronary artery disease.Ann Transl Med. 2019 Sep;7(18):483. doi: 10.21037/atm.2019.08.75. Ann Transl Med. 2019. PMID: 31700919 Free PMC article.
-
Extracellular and intracellular actions of sphingosine-1-phosphate.Adv Exp Med Biol. 2010;688:141-55. doi: 10.1007/978-1-4419-6741-1_10. Adv Exp Med Biol. 2010. PMID: 20919652 Free PMC article. Review.
-
Tumor Necrosis Factor-α Induces a Preeclamptic-like Phenotype in Placental Villi via Sphingosine Kinase 1 Activation.Int J Mol Sci. 2022 Mar 29;23(7):3750. doi: 10.3390/ijms23073750. Int J Mol Sci. 2022. PMID: 35409108 Free PMC article.
-
Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis.Pharmacol Ther. 2007 Sep;115(3):390-9. doi: 10.1016/j.pharmthera.2007.05.011. Epub 2007 Jun 30. Pharmacol Ther. 2007. PMID: 17669501 Free PMC article. Review.
-
The discovery of novel experimental therapies for inflammatory arthritis.Mediators Inflamm. 2009;2009:698769. doi: 10.1155/2009/698769. Epub 2010 Mar 18. Mediators Inflamm. 2009. PMID: 20339519 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous